Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromodomain Y-linked 20 pseudogene (CDY20P) is a pseudogene that does not encode a functional protein product[2][4]. It is related to the chromodomain Y-linked (CDY) gene family, which encodes proteins involved in chromatin organization, but CDY20P itself is a noncoding genomic element that likely arose via gene duplication or retrotransposition and subsequent loss of coding capacity[2][3][4]. Unlike protein-coding targets, pseudogenes like CDY20P may participate in the regulation of gene expression at the RNA level, for example by acting as competing endogenous RNAs or as sources of regulatory non-coding RNAs, but there is no direct evidence for such a function for CDY20P specifically[6][9]. It is not considered a therapeutic target, nor are there known drugs, biomarkers, or specific disease associations directly involving CDY20P[2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromodomain Y-linked 20 pseudogene (CDY20P).